Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
APDN Applied DNA Sciences	$3.19 -1.8%	$4.54	$3.12 ▼ $1,976.25	$4.20M	-0.02	76,718 shs	49,352 shs
CCIHY ChinaCache International	$0.04 -6.7%	$0.04	$0.01 ▼ $0.29	$1.15M	N/A	590,135 shs	2.13 million shs
ISPC iSpecimen	$0.72 -2.7%	$1.08	$0.69 ▼ $8.30	$4.10M	1.65	1.28 million shs	754,325 shs
MWRK MetaWorks Platforms	$0.05 -2.7%	$0.05	$0.00 ▼ $0.05	$5.02M	1.22	226,363 shs	155,830 shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
APDN Applied DNA Sciences	-2.99%	+0.93%	-34.87%	-33.62%	-99.82%
CCIHY ChinaCache International	0.00%	0.00%	0.00%	0.00%	0.00%
ISPC iSpecimen	-7.49%	-35.91%	-32.71%	-38.32%	+155.24%
MWRK MetaWorks Platforms	0.00%	+61.11%	+21.59%	+100.00%	+1,314.63%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
APDN Applied DNA Sciences	0.4394 of 5 stars	0.0	2.0	0.0	0.0	3.3	0.0	0.6
CCIHY ChinaCache International	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ISPC iSpecimen	0.3228 of 5 stars	0.0	2.0	0.0	0.0	3.1	0.8	0.0
MWRK MetaWorks Platforms	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating	Consensus Price Target	% Upside from Current Price
APDN Applied DNA Sciences	N/A	N/A	N/A
CCIHY ChinaCache International	N/A	N/A	N/A
ISPC iSpecimen	N/A	N/A	N/A
MWRK MetaWorks Platforms	N/A	N/A	N/A

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
APDN Applied DNA Sciences	$3.43M	1.20	N/A	N/A	$5.41 per share	0.59
CCIHY ChinaCache International	$131.95M	0.01	N/A	N/A	($3.18) per share	-0.01
ISPC iSpecimen	$9.29M	0.43	N/A	N/A	$0.11 per share	6.55
MWRK MetaWorks Platforms	$410K	12.23	N/A	N/A	($0.01) per share	-5.32

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
APDN Applied DNA Sciences	-$6.99M	-$923.81	N/A	∞	N/A	-399.91%	-136.17%	-101.95%	N/A
CCIHY ChinaCache International	-$7.42M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
ISPC iSpecimen	-$12.50M	-$9.51	N/A	∞	N/A	-172.48%	-395.15%	-121.72%	N/A
MWRK MetaWorks Platforms	-$5.65M	-$0.08	N/A	∞	N/A	N/A	-249.65%	-157.91%	N/A

Latest CCIHY, APDN, ISPC, and MWRK Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/14/2025	Q3 2025	APDN Applied DNA Sciences	-$37.50	-$34.00	+$3.50	-$34.00	$1.28 million	$0.30 million
8/14/2025	Q2 2025	ISPC iSpecimen	-$3.80	-$0.42	+$3.38	-$0.42	$3.10 million	$0.71 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
APDN Applied DNA Sciences	N/A	N/A	N/A	N/A	N/A
CCIHY ChinaCache International	N/A	N/A	N/A	N/A	N/A
ISPC iSpecimen	N/A	N/A	N/A	N/A	N/A
MWRK MetaWorks Platforms	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
APDN Applied DNA Sciences	N/A	2.76	2.60
CCIHY ChinaCache International	N/A	N/A	N/A
ISPC iSpecimen	N/A	0.23	0.23
MWRK MetaWorks Platforms	N/A	0.02	0.02

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
APDN Applied DNA Sciences	22.22%
CCIHY ChinaCache International	N/A
ISPC iSpecimen	13.62%
MWRK MetaWorks Platforms	16.14%

Insider Ownership

Company	Insider Ownership
APDN Applied DNA Sciences	0.03%
CCIHY ChinaCache International	13.70%
ISPC iSpecimen	12.20%
MWRK MetaWorks Platforms	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
APDN Applied DNA Sciences	70	1.29 million	1.29 million	Optionable
CCIHY ChinaCache International	958	27.29 million	N/A	Not Optionable
ISPC iSpecimen	60	5.54 million	4.86 million	Not Optionable
MWRK MetaWorks Platforms	2	94.25 million	N/A	Not Optionable

CCIHY, APDN, ISPC, and MWRK Headlines

Recent News About These Companies

MetaWorks Platforms (OTCMKTS:MWRK) vs. MultiPlan (NYSE:MPLN) Head to Head Review

August 28 at 2:10 AM | americanbankingnews.com

WAST Waste Energy Corp.

January 31, 2025 | seekingalpha.com

MetaWorks rebrands, kicks off new waste reduction plan

December 6, 2024 | rubbernews.comR

Mark Zuckerberg's Nuclear-Powered AI Ambitions At Meta Stung By Rare Bees

November 5, 2024 | msn.com

Meta Platforms: Strong Q3 Performance and Innovative Growth Justifies Buy Rating

October 31, 2024 | markets.businessinsider.com

Meta Platforms: Strong Q3 Results And Amazing Growth Potential

October 31, 2024 | seekingalpha.com

Meta Platforms: Strong Growth Potential Driven by AI Innovations and Monetization Strategies

October 31, 2024 | markets.businessinsider.com

Musk Thinks Threads Is 'Boring,' But 275 Million Monthly Users Signal Zuckerberg's Platform Could Be Real Threat To X

October 31, 2024 | benzinga.com

Meta Platforms: Strong Q3 Performance and AI Advancements Drive Buy Rating

October 31, 2024 | markets.businessinsider.com

Meta Platforms: Strong Financial Performance and Growth Potential Justify Buy Rating

October 31, 2024 | markets.businessinsider.com

Meta Platforms Q3 Earnings: Revenue Beat, EPS Beat, Daily Actives Up 5%, 'Strong Momentum' In AI (CORRECTED)

October 30, 2024 | msn.com

Meta Platforms Q3 Preview: Double Compounding Expected To Continue

October 28, 2024 | seekingalpha.com

Meta Platforms: 4 Key Verticals To Monitor In The Q3 Earnings Report

October 28, 2024 | seekingalpha.com

Meta cuts jobs at WhatsApp and Instagram as Mark Zuckerberg shakes up teams behind world's biggest apps

October 17, 2024 | msn.com

Waste Energy Corp. (MWRK)

October 8, 2024 | finance.yahoo.com

Meta Platforms’ Mark Zuckerberg Becomes World’s Second Richest Person

October 6, 2024 | theglobeandmail.com

Mark Zuckerberg overtakes Jeff Bezos to become 2nd-richest person for the first time — worth $206 billion

October 5, 2024 | businessinsider.com

Meta Platforms, Inc. (META) to Unveil New AI Features and Celebrity Voices for Meta AI Chatbot at Meta Connect Event, Alongside Smart Glasses and Mixed Reality Goggles

September 27, 2024 | msn.com

Meta Connect 2024 recap: Mark Zuckerberg reveals Orion smart glasses, new AI features, transparent Ray-Bans, and an affordable Quest 3S

September 25, 2024 | msn.com

Mark Zuckerberg: creators ‘overestimate the value’ of their work for training AI

September 25, 2024 | theverge.comT

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCIHY, APDN, ISPC, and MWRK Company Descriptions

Applied DNA Sciences NASDAQ:APDN

$3.19 -0.06 (-1.85%)

Closing price 04:00 PM Eastern

Extended Trading

$3.18 -0.02 (-0.47%)

As of 07:55 PM Eastern

Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

ChinaCache International OTCMKTS:CCIHY

$0.04 0.00 (-6.67%)

As of 02/4/2021

ChinaCache International Holdings Ltd., an investment holding company, provides content and application delivery services in the People's Republic of China. The company offers a portfolio of services and solutions to businesses, government agencies, and other enterprises to enhance the reliability and scalability of their online services and applications. Its services include Web page content, file transfer, and rich media streaming services; and guaranteed application services for Websites that have various features, such as online booking and ordering, real-time stock quotes, and online surveys. It also provides managed Internet data services for content and application delivery, and network infrastructure and security; content bridging services for mobile telecommunications carriers; Internet exchange and data center services; and mobile Internet solutions. In addition, the company offers various value-added services, such as geo-content acceleration service, performance evaluation modules, scalable service routing service, link anti-hijack service, user behavior analysis service, Website performance evaluation service, all-around application acceleration solution, and cloud extension solution. Further, the company provides technical consultation services; and leases mechanical equipment. Additionally, it engages in computer hardware and technology development; and real estate management businesses. The company was founded in 1998 and is headquartered in Beijing, the People's Republic of China.

iSpecimen NASDAQ:ISPC

$0.72 -0.02 (-2.73%)

Closing price 04:00 PM Eastern

Extended Trading

$0.72 +0.00 (+0.56%)

As of 07:58 PM Eastern

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

MetaWorks Platforms OTCMKTS:MWRK

$0.05 0.00 (-2.74%)

As of 08/27/2025

MetaWorks Platforms, Inc. provides blockchain and Web3 development platform. It offers turnkey set of services for companies to develop and integrate blockchain and cryptocurrency technologies into their business operations. The company provides business development and technical services; blockchain and technology program management services; customer development services; business launch services; and post-business launch support services. The company was formerly known as CurrencyWorks Inc. and changed its name to MetaWorks Platforms, Inc. in August 2022. MetaWorks Platforms, Inc. was incorporated in 2010 and is based in Fairfield, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time